HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $426 | +4.2% | 11,156 | -1.7% | 0.02% | +12.5% |
Q2 2023 | $409 | +19.2% | 11,350 | +26.3% | 0.02% | +14.3% |
Q1 2023 | $343 | -33.1% | 8,983 | -0.3% | 0.01% | -36.4% |
Q4 2022 | $513 | -99.9% | 9,014 | -16.7% | 0.02% | +29.4% |
Q3 2022 | $428,000 | -15.1% | 10,822 | -5.6% | 0.02% | +13.3% |
Q2 2022 | $504,000 | +57.0% | 11,460 | +42.6% | 0.02% | +87.5% |
Q1 2022 | $321,000 | -13.5% | 8,038 | -12.9% | 0.01% | 0.0% |
Q4 2021 | $371,000 | -0.8% | 9,226 | +0.5% | 0.01% | 0.0% |
Q3 2021 | $374,000 | -14.0% | 9,182 | -4.1% | 0.01% | 0.0% |
Q2 2021 | $435,000 | +74.0% | 9,572 | +59.4% | 0.01% | +60.0% |
Q1 2021 | $250,000 | -55.4% | 6,006 | -54.3% | 0.01% | -58.3% |
Q4 2020 | $561,000 | +62.6% | 13,146 | 0.0% | 0.01% | +50.0% |
Q3 2020 | $345,000 | -2.0% | 13,146 | 0.0% | 0.01% | -11.1% |
Q2 2020 | $352,000 | +47.3% | 13,146 | -1.1% | 0.01% | +28.6% |
Q1 2020 | $239,000 | 0.0% | 13,291 | -1.5% | 0.01% | +40.0% |
Q4 2019 | $239,000 | +11.7% | 13,493 | -2.1% | 0.01% | 0.0% |
Q3 2019 | $214,000 | -10.5% | 13,788 | -0.8% | 0.01% | 0.0% |
Q2 2019 | $239,000 | +4.4% | 13,906 | -2.2% | 0.01% | 0.0% |
Q1 2019 | $229,000 | – | 14,224 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |